Pelican Cancer Foundation derives its name from the words pelvic and liver cancer.
For the public benefit to advance research, education and treatment of cancer, in particular, but not exclusively bowel cancer, other pelvic malignancies, secondary liver cancer and related diseases.
Help colorectal cancer patients live for longer, with a better quality of life. Help cancer specialists advance their understanding and treatment of colorectal cancer.
Help cancer specialists advance their skills and understanding of precision treatment for bowel and secondary liver cancers. Support research investigating innovative, precision cancer treatments. Disseminate knowledge of latest research and advances in precision treatment.
What we do
We focus on improving precision surgery for bowel cancer, secondary liver cancer, and other pelvic malignancies. Pelican was created in 1993 to advance the pioneering colorectal surgical work of Professor Bill Heald CBE, Mr Merv Rees, Mr Brendan Moran, and their colleagues in Basingstoke.
Pelican’s aim is to discover the most effective treatment for patients – refining treatment options to achieve the best outcomes for patients’ survival and quality of life. We work to ensure that these advances are applied in cancer care today.
We achieve this with a cycle of activity of seed funding research and working with clinicians to embed research findings and advances in clinical practice by delivering professional courses for cancer teams.